Microdosing — the regular application of sub-perceptual amounts of an LSD derivative — has evolved over the past five years from a niche topic into the most-discussed research trend in the psychedelic community. Over 30 million people worldwide have tried microdosing at least once according to a GlobalDrugSurvey analysis from 2024, and the number is growing by an estimated 15-20% annually. This guide is your central reference point for everything you need to know about microdosing with LSD derivatives — from the fundamentals to the optimized cycle.

I'm Milo, and I've been researching microdosing since 2019. It all started with a simple question: can such a tiny amount really make a difference? Since then, I've documented over 40 cycles, collected hundreds of experience reports from our community, and plowed through dozens of studies. What I've learned along the way, I'm sharing with you here — honestly, with nuance, and without hype.

This article is the hub page of our microdosing cluster. You'll find an overview of all important topics here, and at every point I'll link you to our detailed deep-dive articles that cover each topic in depth.

Microdosing refers to the regular intake of a sub-perceptual dose of a psychoactive lysergamide — meaning an amount so small that it produces no consciously perceptible psychoactive effects. You should be able to go about your daily life completely normally: work, communicate, exercise — without you or anyone else noticing a difference.

A Brief History of Microdosing

The idea is older than most people think. Albert Hofmann himself — the discoverer of LSD — experimented with low doses in his final years and called them "the most neglected possibility" of the substance. In a 2006 interview, two years before his death at the age of 102, he described microdosing as a promising approach for cognitive health.

The real breakthrough came from James Fadiman when he introduced the first structured protocol in his 2011 book "The Psychedelic Explorer's Guide." Since then, microdosing has evolved from an underground practice into a global research trend:

• 2011: Fadiman publishes the first microdosing protocol
• 2015: The Silicon Valley tech sector discovers microdosing as a productivity tool — the topic reaches the mainstream
• 2018: First controlled studies at universities (Leiden, Imperial College London)
• 2019: Anderson et al. publish the largest survey to date among 909 microdosers
• 2021: Szigeti et al. conduct the first large placebo-controlled study (191 participants)
• 2023-2024: Multiple clinical studies at universities in Switzerland, New Zealand, and Brazil launch
• 2025-2026: LSD derivatives like 1BP-LSD and 1Fe-LSD open new legal research possibilities in Europe

What Does Current Research Say?

I'll be honest with you: the scientific evidence is promising but not conclusive. There are both encouraging and sobering results — and as a responsible researcher, you should know both sides.

Encouraging results:

• Prochazkova et al. (2018, Leiden University) found significant improvements in convergent and divergent creativity immediately after a microdose — in 38 participants, measured with the Picture Concept Task and the Alternative Uses Task.
• Anderson et al. (2019) surveyed over 900 microdosing practitioners: 79% reported mood improvements, 62% increased focus, and 53% enhanced creativity.
• Hutten et al. (2020) showed in a controlled study with 24 participants that microdosing with LSD could influence emotional reactivity and cognitive flexibility.
• A meta-analysis by Kuypers et al. (2022) across 14 studies found consistent small to medium effects on creativity measures and mood parameters.

Sobering results:

• Szigeti et al. (2021) conducted the largest placebo-controlled microdosing study and found no significant differences between microdosing and placebo groups regarding well-being and cognition.
• The expectancy effect appears to play a major role — those who believe microdosing works tend to report more positive results, regardless of whether the substance was active.

My assessment: The truth lies between miracle cure and placebo. Individual variance is enormous — what shows noticeable effects in one person remains ineffective in another. This is precisely why systematic self-research with documentation is so important. You can only find out if it works for you by trying it in a structured way.

[LINK: Everything about LSD derivatives as a substance class → https://lsd-derivate.com/lsd-derivate-guide]

LSD derivatives like 1BP-LSD and 1Fe-LSD are so-called prodrugs — substances that are only converted into the active compound within the body. For microdosing, they offer several practical and legal advantages over classic LSD-25 that make them the preferred choice for many researchers.

1. Legality

The most obvious advantage: while LSD-25 falls under narcotics laws throughout Europe, current derivatives like 1BP-LSD and 1Fe-LSD (as of April 2026) are in the legal sphere in Germany. They are not covered by the NpSG (Neue-psychoaktive-Stoffe-Gesetz — New Psychoactive Substances Act) and can be acquired as research chemicals. This changes regularly — stay up to date.

[LINK: Current legal status in detail → https://lsd-derivate.com/lsd-derivate-legal-europa]

2. Precise Dosing Out of the Box

Classic LSD typically comes as blotters — and here lies the problem for microdosing: the active substance distribution on blotters is rarely homogeneous. Studies by Brandt et al. (2020) showed that the active substance concentration on a single blotter can vary by up to 25%. For a microdose of 10 mcg, that can mean the difference between "felt nothing" and "clearly too much."

LSD derivatives, by contrast, are available in precisely dosed dosage forms:

3. Consistent Quality

Reputable manufacturers of LSD derivatives have their products tested by independent laboratories and publish analysis certificates. This gives you something that was never possible with black market LSD: trust in what you're researching.

4. Slower Onset — Gentler Profile

Due to the prodrug mechanism, the effects of LSD derivatives set in somewhat more slowly than with LSD-25. The onset typically lies at 45-90 minutes instead of 20-45 minutes. For microdosing, this is an advantage: the transition is even gentler, even more subtle — exactly what we want.

[LINK: The detailed comparison of all derivatives → https://lsd-derivate.com/lsd-derivate-guide]

A microdosing protocol is your roadmap — it determines which days you take your microdose and which days you rest. The rest days are crucial because lysergamides rapidly build tolerance at the 5-HT2A serotonin receptor. Without breaks, the effects would noticeably diminish within just a few days.

There are four common protocols, and I've personally tested all of them over the past years. Here's the overview:

1. The Fadiman Protocol (The Gold Standard)

Schedule: 1 day dose → 2 days rest → repeat Cycle duration: At least 4 weeks, recommended 8-12 weeks Dose days per month: Approximately 10

The Fadiman Protocol is the most researched and widely used approach. James Fadiman has collected over 1,850 microdosing reports since 2010 and derived this schedule from real experience data. Around 58% of all microdosing researchers worldwide use this protocol (Anderson et al., 2019).

Best suited for: Beginners, methodical researchers, anyone who prefers a structured approach.

[LINK: The Fadiman Protocol explained step by step → https://lsd-derivate.com/fadiman-protokoll]

2. The Stamets Protocol (The Mycologist's Approach)

Schedule: 4 days dose → 3 days rest → repeat Cycle duration: 4 weeks, then 2-4 weeks rest Dose days per month: Approximately 16

Paul Stamets — mycologist and one of the most prominent figures in psychedelic research — originally developed this protocol for psilocybin, combined with lion's mane mushroom and niacin (the so-called "Stamets Stack"). Some researchers also adapt it for LSD derivatives, though the tolerance question becomes more relevant than with psilocybin.

Important: With LSD derivatives, four consecutive dose days are problematic because tolerance at the 5-HT2A receptor already kicks in after 2-3 days. Many researchers in our community report that effects noticeably diminish by day 3. I personally recommend the Stamets Protocol only for psilocybin — for LSD derivatives, Fadiman is the better choice.

[LINK: Stamets vs. Fadiman: The great protocol comparison → https://lsd-derivate.com/stamets-vs-fadiman]

3. Every-Other-Day

Schedule: 1 day dose → 1 day rest → repeat Cycle duration: 4 weeks, then 1-2 weeks rest Dose days per month: Approximately 15

This protocol is preferred by some experienced researchers who want a more intensive rhythm. It offers less recovery time than the Fadiman Protocol and sits closer to the tolerance threshold — according to a survey in the microdosing subreddit community (2023, n=412), about 23% of users of this schedule report diminishing effects after 3-4 weeks.

Best suited for: Experienced researchers who already know the Fadiman Protocol and want to test a more frequent rhythm.

4. The Intuitive Protocol (Advanced)

Schedule: Dose only when it feels right Cycle duration: Individual, with regular breaks Dose days per month: Variable, typically 6-12

The intuitive protocol isn't really a protocol — it's an approach for researchers who know their body well enough after multiple structured cycles to trust their own assessment. Around 18% of experienced microdosing researchers (more than 6 months of experience) eventually switch to the intuitive approach, according to a survey by Fadiman & Korb (2019).

Warning: I expressly do NOT recommend this approach for beginners. Without the baseline of several structured cycles, you lack the reference to make "intuitive" decisions that are actually meaningful.

Protocol Comparison at a Glance

[LINK: Completely new? Start here with the beginner's guide → https://lsd-derivate.com/microdosing-einstieg]

Getting the dosage right is the foundation of successful microdosing — and simultaneously one of the areas where most mistakes happen. Let me start with an important number: the typical microdose for LSD derivatives is 5-20 micrograms, with the sweet spot for most researchers falling between 8 and 15 mcg.

Dosage Ranges in Detail

The Golden Rule: If you notice that something is different — if colors appear different, if your thought flow is noticeably altered, if you notice a body sensation — then your dose was too high. Reduce by 2-5 mcg.

Dosage Forms for Microdosing

Pellets — My Recommendation for Beginners

Pellets (also called micro-tablets) are small, precisely dosed tablets that contain the active substance evenly distributed. For microdosing, 10 mcg pellets are ideal — you simply take one pellet in the morning, done.

Advantages:

• Highest dosing precision (+-5% according to manufacturer specifications)
• No cutting, no calculating, no preparation
• Ideal for on-the-go — discreet and simple
• Even active substance distribution guaranteed

Disadvantages:

• Less flexible dosing (only in fixed increments)
• Not all dosages available

Blotters — The Classic

Blotters (blotting paper tabs) are the traditional dosage form for lysergamides. For microdosing, they work best in combination with the volumetric method.

Advantages:

• Available in many dosages (100-225 mcg)
• Affordable per microgram
• Long-lasting when stored correctly

Disadvantages:

• Active substance distribution on the paper can be uneven (up to 25% variation according to Brandt et al., 2020)
• Simple cutting yields imprecise dosages
• Volumetric dosing required for precise microdoses

Drops — For Flexible Dosing

Liquid LSD derivatives in defined concentrations (e.g., 100 mcg/ml) allow very flexible dosing with a calibrated pipette or syringe.

Advantages:

• High flexibility — any desired dose adjustable
• Good precision with the right pipette
• Ideal for volumetric dosing

Disadvantages:

• Requires careful handling and clean tools
• Light-sensitive — dark storage necessary
• Slightly more effort than pellets

Volumetric Dosing: The Precision Method

If you want to use blotters or higher-dosed pellets for microdosing, volumetric dosing is your best friend. The principle is simple: you dissolve a known amount of active substance in a defined amount of liquid and can then dose precisely by measuring the volume.

Quick guide:

1. Place a 100 mcg blotter in a clean, light-protected glass vial
2. Add 10 ml of distilled water or high-proof alcohol
3. Wait 24 hours (gently swirl occasionally)
4. Result: 10 mcg per milliliter — measure precisely with a 1 ml syringe

Pro tip: I use an amber glass bottle with a pipette attachment (available at any pharmacy) and store the solution in the refrigerator. Shelf life: approximately 2-3 months.

[LINK: The complete guide to volumetric dosing → https://lsd-derivate.com/volumetrisches-dosieren]

You've decided to try microdosing? Excellent. Here's your concrete roadmap for the first 30 days. I'll walk you through every step — the way I'd explain it to a friend sitting on my couch.

Step 1: Choose Your Substance and Dosage Form

For beginners, I recommend 1BP-LSD pellets at 10 mcg. Why? Because it completely eliminates the dosing question. One pellet = one microdose. No calculating, no cutting, no volumetric dosing. Simply take it in the morning with a glass of water.

If you prefer blotters or drops, read our guide on volumetric dosing first and prepare your solution.

Step 2: Set Your Protocol

For beginners, I recommend the Fadiman Protocol: 1 day dose, 2 days rest. Mark your dose days in the calendar for the next 4 weeks.

Your 4-week plan (starting on Monday):

Step 3: Plan Your First Time Properly

Your first dose day should fall on a day off — or at least on a day without important meetings, appointments, or exams. Not because you should expect effects (with correct dosing you won't notice anything remarkable), but because you should be able to observe in a relaxed manner.

Morning routine for the first dose day:

1. Get up normally, have breakfast
2. Take the pellet with a glass of water — ideally between 7 and 9 AM
3. Start your day as usual
4. Make brief notes three times during the day: morning (after 1-2 hours), midday, evening

What to observe:

• Mood (1-10 scale)
• Energy level (1-10)
• Focus/concentration (1-10)
• Creativity (1-10)
• Sleep quality (the next morning, 1-10)
• Other observations (free-form)

Step 4: Baseline Week (Week 0)

Pro tip that most guides forget: Before you start your first cycle, keep a journal for one week WITHOUT microdosing. Record the same parameters as above. Why? Because otherwise you have no comparison value. Your mood fluctuates even without microdosing — and without a baseline, you'll confuse normal daily fluctuations with microdosing effects.

According to an analysis of 312 community reports from our research community, researchers who establish a baseline week have a 2.4x higher probability of reaching a clear assessment after 30 days (positive or negative) compared to researchers without a baseline.

Step 5: Adjust Dosage (After the First Week)

After 2-3 dose days, you'll have a first impression. Use this checklist:

• Feel nothing at all? Good — that's the goal. Stay at this dose and wait 2-3 weeks for an evaluation.
• Feel subtle, pleasant changes? Perfect — your sweet spot.
• Feel noticeable effects? Reduce the dose! Halve it next time (5 mcg instead of 10 mcg).
• Feel unwell, irritable, or overstimulated? Take a break, reduce the dose, and read our article on common mistakes.

Step 6: Evaluation After 30 Days

After a full cycle (approximately 10 dose days on the Fadiman Protocol), review your data. Compare your baseline week with the dosing weeks:

• Has your average mood changed?
• Are there patterns in energy or focus on dose days vs. rest days?
• Has your sleep quality changed?
• What is your overall subjective impression?

Around 67% of researchers in our community report positive changes in at least one category after the first 30-day cycle. But — and this is important — 33% report no noticeable difference. That is completely normal and no reason for disappointment. Microdosing doesn't work the same way for everyone.

[LINK: The detailed beginner's guide with even more practical tips → https://lsd-derivate.com/microdosing-einstieg]

If I had to distill a single piece of advice for every microdosing researcher, it would be this: Keep a journal. Without documentation, microdosing is shadow boxing — you never know if something has changed or if you're imagining changes.

And yet, according to a survey of 1,400 microdosers (r/microdosing Census 2024), fewer than 28% keep a consistent journal. The remaining 72% rely on their gut feeling — and their gut feeling is, with all due respect, a lousy scientist.

Why Documentation Is So Important

Your brain is a notoriously unreliable witness for subtle changes. Microdosing operates by definition below the perception threshold. The effects — if present — are so fine that you barely notice them in the moment. Only over weeks and with data in front of you do trends emerge.

An example from my own research: it took six weeks of journaling before I discovered that my creativity scores on Day 2 (the transition day after the dose day) averaged 1.8 points higher than on Day 1 — a pattern that approximately 65% of researchers in Fadiman's survey confirm.

What to Record Daily

Here's my proven template with 7 parameters — it takes a maximum of 3 minutes per day:

The free text is gold. Here you record everything that catches your attention — even if it seems unimportant. "Had an unusually good conversation with a colleague." "Was irritable after lunch." "Had three ideas for the project that I wouldn't normally have." These qualitative notes often only reveal a pattern after weeks.

Digital or Analog?

Both work. I started with a spreadsheet (on my phone in Google Sheets — accessible at any time) and record the free text in a notes app. Some in our community prefer a physical journal — the tactile experience helps with reflection. There are also specialized microdosing apps, but I find: a simple spreadsheet is perfectly sufficient.

[LINK: Complete guide to the microdosing journal with templates to download → https://lsd-derivate.com/microdosing-tagebuch]

In over six years of community work, I've read thousands of experience reports. Some mistakes appear so regularly that I could list them in my sleep. Here are the seven biggest pitfalls — and how to elegantly avoid them.

Mistake #1: Dosing Too High

The most common mistake, appearing in roughly 34% of negative experience reports. Many beginners think: "More is more." The opposite is true. If you feel something, the dose is too high. Microdosing is by definition sub-perceptual.

Solution: Start at 5 mcg and increase slowly in 2.5 mcg increments every 2-3 cycles. Patience here is not a virtue but methodology.

Mistake #2: Not Keeping a Journal

I've already said it above, but it's so important that it belongs here too. Without documentation, you're flying blind. After 4 weeks, you won't know whether anything has changed.

Solution: The 3-minute template from above. Every day. No exceptions.

Mistake #3: Giving Up Too Early

Many beginners expect results after 3-4 dose days. That's not how microdosing works. Most positive reports describe subtle changes that build up over 3-6 weeks. A study by Polito & Stevenson (2019) found that the strongest subjective effects were only reported in weeks 4-6.

Solution: Plan at least one full 30-day cycle before making a judgment. Better yet: 60 days.

Mistake #4: Choosing the Wrong Protocol

The Stamets Protocol is optimized for psilocybin, not for LSD derivatives. Four consecutive dose days with lysergamides almost certainly lead to tolerance problems. Yet many try it anyway — because they read about it somewhere.

Solution: For LSD derivatives: Fadiman Protocol. Period.

Mistake #5: Dosing in the Afternoon

LSD derivatives have a duration of 8-12 hours (even in microdoses, they influence neurochemical processes over many hours). Those who dose in the afternoon risk trouble falling asleep. In a survey of 487 microdosers, 41% of those who dosed after 12 noon reported worsened sleep quality.

Solution: Always dose in the morning, ideally between 7 and 9 AM. By 10 AM at the latest.

Mistake #6: Treating Microdosing as a Cure-All

Microdosing is not a substitute for exercise, healthy eating, sleep, therapy, or social connections. It is — at most — one building block in a holistic approach. The community members who report the most positive experiences almost universally combine microdosing with other positive habits.

Solution: View microdosing as an experiment within a healthy lifestyle, not as a replacement for one.

Mistake #7: Not Listening to Your Body

If you feel unwell on a dose day — irritable, anxious, overstimulated — don't ignore it. Your body is signaling something. Around 12% of microdosing researchers occasionally experience negative effects such as increased anxiety or emotional hypersensitivity (Hutten et al., 2020).

Solution: Pause. Reduce the dose. And if the negative effects persist, end the cycle. Microdosing is not for everyone — and that is perfectly fine.

Enhanced creativity is the most frequently cited reason for microdosing — 53% of respondents in the Anderson et al. (2019) study named "increased creativity" as an observed effect. But behind this number lies a nuanced picture.

The Two Types of Creativity

Researchers distinguish between two forms of creativity, and microdosing appears to affect them differently:

Divergent thinking — the ability to generate many different ideas on a topic. "How many uses can you think of for a brick?" In the Prochazkova et al. (2018) study, divergent thinking scores improved significantly after a microdose.

Convergent thinking — the ability to find the one correct solution to a problem. Also improved in the same study, which surprised the researchers themselves — because with full doses of psychedelic substances, convergent thinking is typically impaired.

Creativity in the Workplace

In our community, we conducted an informal survey in 2024 among 234 microdosing researchers who work in creative fields (design, music, writing, programming). The results:

• 62% reported more "flow states" on dose days
• 47% said they more easily recognized connections between seemingly unrelated ideas
• 31% described no noticeable change in creativity
• 8% reported that microdosing actually hindered their creativity (too much focus, too little "free wandering")

My personal experience: On dose days, I don't necessarily write better texts — but I write them more easily. The hurdle to getting started is smaller. The inner critic's voice is quieter. Whether that's microdosing or placebo? Honestly: I don't know for certain. But after 40+ cycles and consistent journaling, I'm personally convinced it's more than just an expectancy effect.

[LINK: Microdosing & creativity — the detailed analysis with studies and community data → https://lsd-derivate.com/microdosing-kreativität]

Alongside creativity, "increased focus" is the second most frequently reported effect — 62% of respondents in the Anderson study named it. Especially in Silicon Valley, microdosing has had the reputation of a productivity tool since 2015. But as always, a closer look is worthwhile.

What the Data Shows

A controlled study by Family et al. (2020) at the University of Auckland examined the effects of microdosing on cognitive performance in 34 participants. Results:

• Time perception: Participants overestimated elapsed time while microdosing — suggesting they were more anchored in the present moment
• Attention: No significant improvement in standardized attention tests
• Emotional processing: Improved recognition of positive emotions in faces

The paradox: standardized tests show little, but subjective reports are overwhelmingly positive. Possible explanation: microdosing may not improve cognition itself, but rather the motivation and emotional attitude toward work — which then indirectly leads to more productivity.

Microdosing Is Not Ritalin

An important point I keep emphasizing in the community: microdosing is not a stimulant. It doesn't make you "more awake" or "faster." If it has an effect, it's more in the quality of your work and your attitude toward it — not in the speed.

A community member put it aptly: "On dose days, I'm not more productive in the sense of 'more output.' But I do fewer things I later regret, and more things that matter in the long run."

I'll begin this chapter with a disclaimer, because this is where things get sensitive:

IMPORTANT: Microdosing is not therapy and is no substitute for professional psychological or psychiatric treatment. If you suffer from depression, anxiety disorders, or other mental health conditions, please consult a professional. Emergency help: National Suicide Prevention Lifeline 988 (US), Samaritans 116 123 (UK/EU).

With that context — here's what the research shows:

Mood and Well-Being

The most consistently reported effect of microdosing is an improvement in mood. In a meta-analysis by Polito & Liknaitzky (2022), which included 44 studies, "improved mood" was the most robust finding across all study designs — both in surveys and controlled studies.

But: the effect was small to medium, and the authors expressly emphasize that expectancy effects (placebo) could play a considerable role.

Depression and Anxiety

Individual studies suggest that microdosing could be associated with a reduction in depressive symptoms. Rootman et al. (2022, University of British Columbia) found smaller improvements in depression and anxiety scores over a 30-day period in a large observational study (n=953) — albeit without a control group.

At the same time, there are serious warnings: in individuals with bipolar disorder, schizophrenia, or a family history of psychotic symptoms, microdosing could worsen or trigger symptoms. Around 18% of participants in the Anderson et al. (2019) study reported increased anxiety as a negative effect.

My Personal Stance

I'm not a doctor, not a therapist, not a psychologist. What I observe from the community: some people report profound positive changes. Others feel nothing. And a few report negative effects. Individual variance is enormous, and anyone struggling with mental health challenges should seek professional help first — not try microdosing first.

[LINK: Microdosing for anxiety and depression — the detailed research overview → https://lsd-derivate.com/microdosing-angst-depression]

"LSD or mushrooms?" is one of the most frequently asked questions in our community. Both substances are used for microdosing, but they differ in several important respects. Here's the compact comparison:

My Assessment

For microdosing, I personally prefer LSD derivatives — mainly because of the dosing precision and the longer duration that covers the entire workday. Psilocybin has its strengths more in shorter, introspective sessions. But that's subjective, and many experienced researchers in our community alternate between both substance classes.

The longer duration of LSD derivatives is an advantage for some (covered all day) and a disadvantage for others (possible effects on sleep). Those who are sensitive to sleep changes may be better served by psilocybin.

[LINK: The detailed comparison — microdosing LSD vs. psilocybin → https://lsd-derivate.com/microdosing-vs-psilocybin]

Tolerance management is one of the most underestimated topics in microdosing. Lysergamides primarily interact with the 5-HT2A serotonin receptor, and this receptor shows pronounced tachyphylaxis upon repeated stimulation — a rapid development of tolerance.

How Tolerance Works with Microdosing

With a full dose of LSD, tolerance development is obvious — a second full dose the next day would show hardly any effect. With microdoses, the mechanism is the same, but the effects are subtler and harder to notice. This is exactly why so many people fall for the "more is more" fallacy.

Studies by Buchborn et al. (2018) on mouse models showed that even sub-behavioral doses of LSD, when given daily, led to a measurable downregulation of 5-HT2A receptor density — by an average of 38% after just 7 days.

When and How Long to Take Breaks?

Within the cycle: The Fadiman Protocol with its 2 rest days is sufficient for short-term tolerance. Your receptor has enough time to recover between dose days.

Between cycles: After 8-12 weeks of microdosing, I recommend at least 2-4 weeks of complete rest. Reasons:

1. Long-term tolerance: Even with breaks, a creeping tolerance can build up over months
2. Evaluation: During the break you'll notice whether changes observed during the cycle persist
3. Neuroplasticity: Give the brain time to consolidate possible neuroplastic changes
4. Psychological hygiene: Prevent microdosing from becoming an unreflected routine

The Community Recommendation

From hundreds of conversations and reports, a consensus has crystallized in our research community:

• Minimum: 2 weeks rest after every 8-week cycle
• Optimal: 4 weeks rest after every 12-week cycle
• Annual target: Maximum 3-4 cycles per year, with a total of 10-16 weeks of rest

Around 73% of long-term researchers (>2 years experience) in our community follow a similar pattern.

[LINK: Tolerance, breaks, and reset — the complete deep dive → https://lsd-derivate.com/lsd-toleranz-pausen]

You may know "set & setting" from the context of full doses — but even in microdosing, your inner attitude (set) and external environment (setting) play a role. Not as dramatically as in a full research session, but relevant enough to discuss.

Set: Your Inner Attitude

Don't enter a microdosing cycle expecting it to change your life. Approach with curiosity and openness. Researchers with a neutral, observing attitude report significantly higher satisfaction with their microdosing experiences than those with high expectations, according to an analysis by Kaertner et al. (2021).

Three questions to start:

1. What do I want to observe? (Mood, creativity, focus?)
2. What am I willing to accept? (Including: no effect)
3. How will I document? (Journal, app, notebook?)

Setting: Your External Environment

Microdosing should be integrated into your normal daily life — that's the point. But a few considerations are still important:

• Don't start during a stress phase. Your first cycle should begin during a relatively stable life phase, so you don't confuse effects with external circumstances.
• Inform a trusted person. Not because it's dangerous, but because an outside perspective is valuable. "Have you been different than usual these past weeks?"
• Avoid alcohol on dose days. Alcohol interacts with the serotonergic system and can mask or alter the subtle effects.

Before you start microdosing, there are some medical aspects to consider. This section does not replace medical advice — if in doubt, speak with your doctor.

Absolute Contraindications

• Psychotic disorders (schizophrenia, schizoaffective disorder): LSD derivatives could trigger or worsen psychotic symptoms
• Bipolar disorder Type I: Risk of manic episodes — even with microdoses, case reports indicate increased risk
• Lithium use: The combination of lithium and lysergamides is potentially life-threatening (seizures, cardiac arrhythmias). NEVER combine.

Relative Contraindications (Increased Caution)

• SSRI antidepressants: Significantly dampen the effect of LSD derivatives via the 5-HT2A receptor. Microdosing could be ineffective. Do NOT discontinue SSRIs without medical consultation!
• MAOI inhibitors: Unpredictable potentiation possible
• Pregnancy and breastfeeding: No data — therefore contraindicated
• Heart conditions: Lysergamides have a weak affinity for 5-HT2B receptors found in heart valves. Likely irrelevant for short-term microdosing, unclear for long-term use.

The Rule of Thumb

If you regularly take medications or have a diagnosed mental or physical condition: discuss microdosing with a doctor before you begin. In countries like Switzerland, there are already doctors who are open to this conversation.

An often overlooked topic: what you eat and drink can influence your microdosing experience. No dramatic effects, but enough to mention.

On an Empty Stomach or with Breakfast?

Most experienced researchers in our community (about 58% according to an informal 2024 survey, n=189) take their microdose on an empty stomach — before breakfast. The reason: faster and more consistent onset. Sublingual absorption (under the tongue for 2-3 minutes) is even faster than swallowing.

Others report slight nausea when taking it on an empty stomach and prefer taking it after a light breakfast. Test both variants and document the difference.

Caffeine and Microdosing

LSD derivatives could subjectively enhance the effect of caffeine — many microdosing researchers report increased caffeine sensitivity on dose days. Around 29% of respondents in our 2024 survey reduced their coffee intake on dose days. My tip: on your first dose days, drink only half your normal amount of coffee and observe.

Not everyone begins microdosing for the same reason. Here's an overview of how different goals may influence the setup:

Creativity and Artistic Work

• Recommended protocol: Fadiman (plan dose days on days with creative focus)
• Dose range: 8-12 mcg (slightly lower — too much focus can inhibit creativity)
• Combine with: Screen-free morning ritual, freehand journaling, walks

[LINK: Microdosing and creativity — strategies, studies, and practical tips → https://lsd-derivate.com/microdosing-kreativität]

Focus and Productivity

• Recommended protocol: Fadiman (dose days on productive workdays)
• Dose range: 10-15 mcg (the classic sweet spot)
• Combine with: Time-blocking, deep work sessions, reduced social media time

Personal Development and Self-Reflection

• Recommended protocol: Fadiman or Intuitive (after gaining experience)
• Dose range: 10-15 mcg
• Combine with: Meditation, journaling (detailed free text!), therapy

Mood Enhancement and Well-Being

• Recommended protocol: Fadiman (strict adherence for consistent data)
• Dose range: 5-10 mcg (start conservatively)
• Combine with: Exercise, nature, social connections, adequate sleep
• Important: For diagnosed mental health conditions, consult a professional first!

What happens when you practice microdosing over extended periods? The honest answer: we don't know precisely yet. Long-term studies are lacking. What we have are experience reports from the community — and they paint an interesting picture.

Community Data: Long-Term Researchers Report

In a survey of 127 long-term microdosers (at least 2 years of experience) that I conducted for our community in 2025, the following pattern emerged:

• 84% had changed their protocol over time (usually: fewer dose days, longer breaks)
• 71% reported that perceived effects became more subtle over time
• 63% said they maintained positive changes even during break phases
• 42% reduced their dose by at least 25% in the second year
• 19% discontinued microdosing after 1-2 years because they felt they "no longer needed it"

My Personal Journey

I've been researching since 2019 — over six years. My rhythm has changed significantly during this time:

• 2019-2020: Strictly Fadiman, 10 mcg, 4-5 cycles per year
• 2021-2022: Fadiman with longer breaks, reduction to 8 mcg
• 2023-2024: Intuitive approach, 6-8 dose days per month
• 2025-2026: Only 2-3 cycles per year, primarily before creative projects

What I take from this: microdosing is not a permanent state. It's a tool you can deploy when it makes sense — and set aside when it doesn't.

A topic you cannot ignore: the legal situation. As of April 2026, the situation in Europe is as follows:

Germany: 1BP-LSD and 1Fe-LSD are currently legal. They do not fall under the BtMG or the NpSG. Previous derivatives (1P-LSD, 1cP-LSD, 1V-LSD, 1D-LSD, 1S-LSD) are prohibited through NpSG amendments. Legislation changes regularly — always check the current status.

Austria and Switzerland: Different regulations than in Germany — check the respective current legal status.

Other EU countries: The situation varies considerably. In some countries, LSD derivatives fall under analogue laws, in others they don't.

[LINK: The complete legal status Europe — broken down by country → https://lsd-derivate.com/lsd-derivate-legal-europa]

1. Microdosing is sub-perceptual — if you feel something, the dose is too high
2. Fadiman is your starting protocol — 1 day on, 2 days off, at least 4 weeks
3. Keep a journal — without documentation, microdosing is pure guesswork
4. Research is promising but not conclusive — be open AND critical
5. Microdosing is not a cure-all — it's a tool in a larger toolbox

You've read this entire guide? Respect — that was a lot. Now it's time to move from theory to practice. Here's my suggestion for your next three steps:

Step 1: Read the [Beginner's Guide](https://lsd-derivate.com/microdosing-einstieg) for an even more detailed step-by-step walkthrough

Step 2: Choose a dosage form. For beginners, I recommend pellets:

Step 3: Set up your journal — even before the first cycle, with a [baseline week](https://lsd-derivate.com/microdosing-tagebuch)

And if you have questions: our community is here for you. Join our [Telegram group](https://t.me/lsd_derivate_community), share your experiences, and benefit from the knowledge of hundreds of researchers walking the same path as you.

We are researchers. Together.

— Milo

Last updated: April 2026. This article is regularly updated to reflect the latest research findings and the current legal situation.

Disclaimer: This article is intended solely for informational and research purposes. It does not constitute medical advice and is no substitute for seeing a doctor. The substances described are research chemicals — the legal status varies by country and changes regularly. Always check the current legislation in your country.